Prescription drug costs

President Donald Trump speaks during an event about prescription drug prices with Health and Human Services Secretary Alex Azar, left, in the Rose Garden of the White House in Washington, Friday, May 11, 2018. (AP Photo/Carolyn Kaster)
May 11, 2018 - 3:04 pm
WASHINGTON (AP) — President Donald Trump's long-awaited plan to bring down drug prices, unveiled Friday, will mostly spare the pharmaceutical industry he previously accused of "getting away with murder" and instead focus on increasing private competition and requiring more openness about costs. In...
Read More
President Donald Trump and Secretary of Health and Human Services Alex Azar arrive for an event about prescription drug prices in the Rose Garden of the White House, Friday, May 11, 2018, in Washington. (AP Photo/Evan Vucci)
May 11, 2018 - 2:55 pm
WASHINGTON (AP) — The Latest on President Donald Trump's plan to reduce drug prices (all times local): 2:45 p.m. President Donald Trump and his health secretary are laying out new proposals designed to reduce drug prices, including a requirement that drugmakers disclose the cost of their medicines...
Read More
FILE - In this Friday, July 8, 2016 file photo, a prescription is filled at a pharmacy in Sacramento, Calif. On Friday, May 11 2018, Trump is scheduled to give his first speech on how his administration will seek to lower drug prices. (AP Photo/Rich Pedroncelli, File)
May 11, 2018 - 12:29 pm
WASHINGTON (AP) — After more than a year of bold promises, President Donald Trump is unveiling his plans for reducing drug prices. But they don't include a key campaign pledge to use the buying power of the government's Medicare program to negotiate lower costs for seniors. In advance of Trump's...
Read More
FILE - In this Friday, July 8, 2016 file photo, a prescription is filled at a pharmacy in Sacramento, Calif. On Friday, May 11 2018, Trump is scheduled to give his first speech on how his administration will seek to lower drug prices. (AP Photo/Rich Pedroncelli, File)
May 11, 2018 - 10:20 am
WASHINGTON (AP) — President Donald Trump is set to unveil his long-awaited plan for reducing drug prices after more than a year of bold promises to tackle pharmacy costs that are squeezing millions of Americans. But the strategy to be outlined in a speech Friday will not include a key Trump...
Read More
FILE - In this Friday, July 8, 2016 file photo, a prescription is filled at a pharmacy in Sacramento, Calif. On Friday, May 11 2018, Trump is scheduled to give his first speech on how his administration will seek to lower drug prices. (AP Photo/Rich Pedroncelli, File)
May 11, 2018 - 10:19 am
WASHINGTON (AP) — President Donald Trump is set to unveil his long-awaited plan for reducing drug prices. The strategy will be outlined in a speech Friday. It comes after more than a year of promises to tackle pharmacy costs that are squeezing millions of Americans. The administration is not...
Read More
FILE - In this Friday, July 8, 2016 file photo, a prescription is filled at a pharmacy in Sacramento, Calif. On Friday, May 11 2018, Trump is scheduled to give his first speech on how his administration will seek to lower drug prices. (AP Photo/Rich Pedroncelli, File)
May 10, 2018 - 8:07 pm
WASHINGTON (AP) — Before taking office, President Donald Trump railed against the pharmaceutical industry and accused it of "getting away with murder." The populist rhetoric appears to be giving way to a more nuanced strategy focused on making the pharmaceutical market more open and competitive,...
Read More
FILE - In this June 14, 2016, file photo, Valeant Pharmaceuticals chairman and CEO Joe Papa speaks to reporters after the company's annual meeting in Laval, Quebec. Valeant Pharmaceuticals now wants to be called Bausch Health Companies, as the Canadian drugmaker continues to distance itself from notoriety gained a few years ago by dramatically hiking the prices of treatments it acquired. Papa said in a statement that the new identity was “a major step forward” in his company’s transformation. (Ryan Remiorz/The Canadian Press via AP, File)
May 08, 2018 - 9:38 am
NEW YORK (AP) — Valeant Pharmaceuticals, which fell under withering scrutiny after acquiring the rights to drugs and then drastically raising their prices, is changing its name. The Canadian company said Tuesday that it will be called Bausch Health Companies Inc. starting in July. CEO Joseph Papa...
Read More
FILE - In this June 14, 2016, file photo, Valeant Pharmaceuticals chairman and CEO Joe Papa speaks to reporters after the company's annual meeting in Laval, Quebec. Valeant Pharmaceuticals now wants to be called Bausch Health Companies, as the Canadian drugmaker continues to distance itself from notoriety gained a few years ago by dramatically hiking the prices of treatments it acquired. Papa said in a statement that the new identity was “a major step forward” in his company’s transformation. (Ryan Remiorz/The Canadian Press via AP, File)
May 08, 2018 - 9:36 am
NEW YORK (AP) — Valeant Pharmaceuticals, which fell under withering scrutiny after acquiring the rights to drugs and then drastically raising their prices, is changing its name. The Canadian company said Tuesday that it will be called Bausch Health Companies Inc. starting in July. CEO Joseph Papa...
Read More
FILE - In this June 14, 2016, file photo, Valeant Pharmaceuticals chairman and CEO Joe Papa speaks to reporters after the company's annual meeting in Laval, Quebec. Valeant Pharmaceuticals now wants to be called Bausch Health Companies, as the Canadian drugmaker continues to distance itself from notoriety gained a few years ago by dramatically hiking the prices of treatments it acquired. Papa said in a statement that the new identity was “a major step forward” in his company’s transformation. (Ryan Remiorz/The Canadian Press via AP, File)
May 08, 2018 - 8:41 am
NEW YORK (AP) — Valeant Pharmaceuticals, which came under heavy scrutiny for acquiring the rights to drugs and then drastically raising their prices, is changing its name. The Canadian company said Tuesday that it will now be called Bausch Health Companies. CEO Joseph Papa said in a prepared...
Read More
FILE - In this Aug. 15, 2017, file photo, Martin Shkreli is interviewed by Maria Bartiromo during her "Mornings with Maria Bartiromo" program on the Fox Business Network, in New York. The pharmaceutical-industry entrepreneur vilified for jacking up the price of a lifesaving drug has been placed in a low-security federal prison in New Jersey. Shkreli was moved Tuesday, April 17, 2018, from the Brooklyn Metropolitan Detention Center in New York to the Federal Correctional Institution at Fort Dix. (AP Photo/Richard Drew, File)
April 19, 2018 - 6:47 am
FORT DIX, N.J. (AP) — The pharmaceutical-industry entrepreneur vilified for jacking up the price of a life-saving drug has been placed in a low-security federal prison in New Jersey. Martin Shkreli was moved Tuesday from the Brooklyn Metropolitan Detention Center in New York to the Federal...
Read More

Pages